Publications

5674 Results

Adjuvant combination chemotherapy (CMFVP) vs oophorectomy followed by CMFVP (OCMFVP) for postmenopausal women with ER+ operable breast cancer with positive (+) axillary lymph nodes: An Intergroup study.

Authors
S Rivkin;S Green;B Metch;A Cruz;D Tesh;J Glick;W Knight;CK Osborne
Journal / Conference
ASCO 10:47(#64)
Year
1991
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Megesterol acetate (MA) and aminoglutethimide/hydrocortisone (AG) in sequence or in combination as second-line endocrine therapy of estrogen receptor positive metastatic breast cancer: A Southwest Oncology Group study.

Authors
J Congdon;S Green;J O'Sullivan;HE Hynes;R Belt;K Gail;B Zidar;CK Osborne
Journal / Conference
ASCO 10:43(#45)
Year
1991
Research Committee(s)
Breast
Study Number(s)
SWOG-8312

Intergroup esophageal study: Comparison of radiotherapy to radio-chemotherapy combination: A phase III trial.

Authors
A Herskovic;K Martz;M Al-Sarraf;L Leichman;JS Brindle;VK Vaitkevicius;J Cooper;R Byhardt;L Davis;B Emami
Journal / Conference
ASCO 10:135(#407)
Year
1991
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8598

A phase III trial of recombinant human interferon-gamma (IFN) as adjuvant therapy of high risk malignant melanoma (MM).

Authors
FL Meyskens;K Kopecky;M Samson;D Noyes;R Tuthill;E Hersh;J Macdonald;H Jaffe;J Crowley;C Coltman, Jr
Journal / Conference
ASCO 10:291(#1019)
Year
1991
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8642

Evaluation of amonafide in disseminated malignant melanoma: A Southwest Oncology Group study.

Authors
M Slavik;K Kopecky;J Craig;V Sondak;M Samson
Journal / Conference
ASCO 10:292(#1022)
Year
1991
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8723

A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group study.

Authors
BL Zidar;B Metch;L Militello;S Balcerzak;H Pierce
Journal / Conference
ASCO 10:350(#1245)
Year
1991
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8731

Comparison of standard dose cisplatin, high dose cisplatin, and high dose cisplatin plus mitomycin in metastatic non small cell lung cancer: Preliminary results of a phase II study. UC Davis/VAMC Martinez and Southwest Oncology Group.

Authors
DR Gandara;MT Tanaka;J Crowley;RB Livingston
Journal / Conference
ASCO 10:246(#843)
Year
1991
Research Committee(s)
Lung
Study Number(s)
SWOG-8738

An intensive six course (c) alternating induction regimen for patients (pts) with advanced squamous cell cancers of the head & neck. A Wayne State University and Southwest Oncology Group pilot study.

Authors
J Ensley;JA Kish;E Tapazoglou;J Jacobs;R Mathog;M Al-Sarraf;D Schuller;B Metch;C Coltman, Jr
Journal / Conference
ASCO 10:205(#682)
Year
1991
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8803

Concurrent cisplatin (DDP), VP-16, and chest irradiation (RT) followed by surgery for stages IIIa and IIIb non-small cell lung cancer (NSCLC): A Southwest Oncology Group study.

Authors
K Albain;V Rusch;J Crowley;B Griffin;K Beasley;R Livingston
Journal / Conference
ASCO 10:244(#836)
Year
1991
Research Committee(s)
Lung
Study Number(s)
SWOG-8805

Treatment of advanced breast cancer with 5-FU and high dose folinic acid.

Authors
K Margolin;J Doroshow;S Green;S Akman;L Leong;R Morgan;J Raschko;G Somlo;L Hutchins;CK Osborne
Journal / Conference
ASCO 10:59(#110)
Year
1991
Research Committee(s)
Breast
Study Number(s)
SWOG-8811